Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardiff Oncology (CRDF) Return on Capital Employed (2016 - 2025)

Cardiff Oncology (CRDF) has disclosed Return on Capital Employed for 14 consecutive years, with 1.05% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 32.0% to 1.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.05% through Dec 2025, down 32.0% year-over-year, with the annual reading at 0.78% for FY2025, 14.0% down from the prior year.
  • Return on Capital Employed hit 1.05% in Q4 2025 for Cardiff Oncology, down from 0.98% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.16% in Q1 2021 to a low of 1.05% in Q4 2025.
  • Historically, Return on Capital Employed has averaged 0.53% across 5 years, with a median of 0.49% in 2023.
  • Biggest five-year swings in Return on Capital Employed: soared 206bps in 2021 and later tumbled -36bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.21% in 2021, then plummeted by -71bps to 0.36% in 2022, then plummeted by -71bps to 0.61% in 2023, then fell by -20bps to 0.73% in 2024, then plummeted by -44bps to 1.05% in 2025.
  • Business Quant data shows Return on Capital Employed for CRDF at 1.05% in Q4 2025, 0.98% in Q3 2025, and 0.85% in Q2 2025.